Search Results - "Morio Sawamura"

Expression of L‐type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma by Isoda, Atsushi, Kaira, Kyoichi, Iwashina, Masanori, Oriuchi, Noboru, Tominaga, Hideyuki, Nagamori, Shushi, Kanai, Yoshikatsu, Oyama, Tetsunari, Asao, Takayuki, Matsumoto, Morio, Sawamura, Morio

“…L‐type amino‐acid transporter 1 (LAT1) plays a key role in cell growth and survival. To determine the prognostic significance of LAT1 in multiple myeloma (MM),…”
Get full text

Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin by Isoda, Atsushi, Miyazawa, Yuri, Tahara, Kenichi, Mihara, Masahiro, Saito, Akio, Matsumoto, Morio, Sawamura, Morio

“…We herein report a 64-year-old man who was treated with pembrolizumab for relapsed Hodgkin lymphoma. After the third administration of pembrolizumab, he showed…”
Get full text

Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma by Suzuki, Yasuhiro, Yano, Takahiro, Suehiro, Youko, Iwasaki, Hiromi, Hidaka, Michihiro, Otsuka, Maki, Sunami, Kazutaka, Ikeda, Hirokazu, Sawamura, Morio, Ito, Takuo, Iida, Hiroatsu, Nagai, Hirokazu

“…Recently, progression of disease within 24 months (POD24) has been demonstrated as a strong prognostic indicator in various types of malignant lymphoma…”
Get full text

Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study by Watanabe, Dai, Uehira, Tomoko, Suzuki, Sachiko, Matsumoto, Erina, Ueji, Takashi, Hirota, Kazuyuki, Minami, Rumi, Takahama, Soichiro, Hayashi, Kimikazu, Sawamura, Morio, Yamamoto, Masahiro, Shirasaka, Takuma

“…Circulating interferon-γ (IFN-γ) concentration may be sustained at a high level regardless of the initiation of antiretroviral therapy (ART) in some patients…”
Get full text

Alternating bortezomib-dexamethasone and lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma aged over 75 years by Yokoyama, Akihiro, Kada, Akiko, Kagoo, Toshiya, Hidaka, Michihiro, Iida, Hiroatsu, Miyata, Yasuhiko, Saito, Akiko M, Sawamura, Morio, Komeno, Takuya, Sunami, Kazutaka, Takezako, Naoki, Nagai, Hirokazu

“…More than 40% of Japanese patients with multiple myeloma (MM) are over 75 years of age at diagnosis. Regardless of the treatment benefits, complications and…”
Get full text

PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma by Kasamatsu, Tetsuhiro, Awata, Maaya, Ishihara, Rei, Murakami, Yuki, Gotoh, Nanami, Matsumoto, Morio, Sawamura, Morio, Yokohama, Akihiko, Handa, Hiroshi, Tsukamoto, Norifumi, Saitoh, Takayuki, Murakami, Hirokazu

“…Single-nucleotide polymorphisms (SNPs) of the programmed cell death protein-1 ( PDCD1 ), programmed cell death protein-1 ligand-1 ( PDCD1LG1 ), and cytotoxic T…”
Get full text

Phase II Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Over 75 Years Old with Alternating Bortezomib/dexamethasone and Lenalidomide/dexamethasone: the MARBLE Trial by Yokoyama, Akihiro, Kada, Akiko, Saito, Akiko M, Sawamura, Morio, Komeno, Takuya, Sunami, Kazutaka, Takezako, Naoki

“…Elderly multiple myeloma (MM) patients, who are generally ineligible for transplantation, have high risks of death and treatment discontinuation, and require a…”
Get full text

Palonosetron, aprepitant, and dexamethasone for prevention of nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: A phase II study by Isoda, Atsushi, Saito, Rie, Komatsu, Fuminori, Negishi, Yuki, Oosawa, Noriyasu, Ishikawa, Tetsuya, Miyazawa, Yuri, Matsumoto, Morio, Sawamura, Morio, Manaka, Akihiro

“…Chemotherapy-induced nausea and vomiting (CINV) is a significant side effect in multiple myeloma (MM) patients receiving high-dose melphalan treatment followed…”
Get full text

Efficacy of Intravenous Itraconazole Versus Liposomal Amphotericin B as Empirical Antifungal Therapy in Hematological Malignancy with Persistent Fever and Neutropenia: Study Protocol for a Multicenter, Prospective, Randomized Non-inferiority Trial by Saito, Akiko M, Yoshida, Isao, Tanaka, Shiro, Sawamura, Morio, Hidaka, Michihiro, Yoshida, Shinichiro, Uike, Naokuni, Kaneko, Yukihiro, Miyazaki, Yoshitsugu, Nagai, Hirokazu

“…Febrile neutropenia, a serious complication that can occur during the treatment of hematological malignancies, can sometimes be fatal owing to fungal…”
Get more information

Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1 by Tanaka, Masashi, Yamakage, Hajime, Muranaka, Kazuya, Yamada, Tsutomu, Araki, Rika, Ogo, Atsushi, Matoba, Yuka, Watanabe, Tetsuhiro, Saito, Miho, Kurita, Seiichiro, Yonezawa, Kazuya, Tanaka, Tsuyoshi, Suzuki, Masahiro, Sawamura, Morio, Matsumoto, Morio, Nishimura, Motonobu, Kusakabe, Toru, Wada, Hiromichi, Hasegawa, Koji, Kotani, Kazuhiko, Noda, Mitsuhiko, Satoh-Asahara, Noriko

“…Type 2 diabetes is a risk factor for dementia. We investigated whether serum levels of soluble triggering receptor expressed on myeloid cell 2 (sTREM2), a…”
Get full text

Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults by Suzuki, Yasuhiro, Yano, Takahiro, Suehiro, Youko, Iwasaki, Hiromi, Hidaka, Michihiro, Otsuka, Maki, Sunami, Kazutaka, Inoue, Nobumasa, Sawamura, Morio, Ito, Takuo, Iida, Hiroatsu, Nagai, Hirokazu

“…Clinical information regarding non-Hodgkin lymphoma (NHL) in adolescents and young adults (AYA) is lacking. We retrospectively analyzed 1426 consecutively…”
Get full text

High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura by Takase, Ken, Nagai, Hirokazu, Kadono, Moe, Yoshioka, Takanori, Yoshio, Nobuyuki, Hirabayashi, Yukio, Ito, Takuo, Sawamura, Morio, Yokoyama, Akihiro, Yoshida, Shinichiro, Tsutsumi, Ikuyo, Otsuka, Maki, Suehiro, Youko, Hidaka, Michihiro, Yoshida, Isao, Yokoyama, Hisayuki, Inoue, Hitoshi, Iida, Hiroatsu, Nakayama, Maki, Hishita, Terutoshi, Iwasaki, Hiromi, Kada, Akiko, Saito, Akiko M., Kuroda, Yoshiaki

“…There is a controversy which short term high dose dexamethasone therapy (HDD) or standard dose prednisolone therapy as the initial treatment leads to long term…”
Get full text

SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients by Mitsui, Takeki, Koiso, Hiromi, Nakahashi, Hirotaka, Saitoh, Akio, Shimizu, Hiroaki, Ishizaki, Takuma, Ogawa, Yoshiyuki, Takizawa, Makiko, Yokohama, Akihiko, Saitoh, Takayuki, Jinbo, Takahiro, Ogura, Hidemi, Handa, Hiroshi, Sawamura, Morio, Sakura, Tohru, Karasawa, Masamitsu, Murakami, Hirokazu, Nojima, Yoshihisa, Tsukamoto, Norifumi

“…The incidence of chronic lymphocytic leukemia (CLL) is low in Japan. The clinical course ranges from very indolent to rapidly progressive. Recently, several…”
Get full text

High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm Trial by Takase, Ken, Kada, Akiko, Iwasaki, Hiromi, Yoshida, Isao, Sawamura, Morio, Yoshio, Nobuyuki, Yoshida, Shinichiro, Iida, Hiroatsu, Otsuka, Maki, Takafuta, Toshiro, Ogata, Yuko, Suehiro, Youko, Hirabayashi, Yukio, Hishita, Terutoshi, Yoshida, Chikamasa, Ito, Takuo, Hidaka, Michihiro, Tsutsumi, Ikuyo, Saito, Akiko M, Nagai, Hirokazu

“…Standard therapy for idiopathic thrombocytopenic purpura (ITP) has not been established. We are conducting a multicenter, prospective trial to determine the…”
Get full text

Silent venous thromboembolism in multiple myeloma patients treated with lenalidomide by Isoda, Atsushi, Sato, Naru, Miyazawa, Yuri, Matsumoto, Yoshinobu, Koumoto, Mina, Ookawa, Masahito, Sawamura, Morio, Matsumoto, Morio

“…Lenalidomide treatment in combination with dexamethasone and/or chemotherapy is associated with a significant risk of venous thromboembolism (VTE) in patients…”
Get full text

Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis by Shimazaki, Chihiro, Fuchida, Shin-ichi, Suzuki, Kenshi, Ishida, Tadao, Imai, Hirokazu, Sawamura, Morio, Takamatsu, Hiroyuki, Abe, Masahiro, Miyamoto, Toshihiro, Hata, Hiroyuki, Yamada, Masahito, Ando, Yukio

“…We performed a phase 1 study to evaluate the safety and feasibility of bortezomib (BOR) with melphalan and dexamethasone (BMD) in patients with light chain…”
Get full text

Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia by Tagami, Tetsuya, Kimura, Hironori, Ohtani, Sumire, Tanaka, Tsuyoshi, Tanaka, Takashi, Hata, Shiro, Saito, Miho, Miyazaki, Yasushi, Araki, Rika, Tanaka, Masami, Yonezawa, Kazuya, Sawamura, Morio, Ise, Takuyuki, Ogo, Atsushi, Shimbo, Takuro, Shimatsu, Akira, Naruse, Mitsuhide

“…Hypercholesterolemia is one of the most representative disorders of the common diseases. To evaluate the prevalence of hypothyroidism in the population of…”
Get full text

Clinical management and outcomes of completely resected stage I follicular lymphoma by Yokohama, Akihiko, Hashimoto, Yoko, Takizawa, Makiko, Shimizu, Hiroaki, Miyazawa, Yuri, Saitoh, Akio, Toyama, Kohtaro, Ishizaki, Takuma, Mitsui, Takeki, Hiromi, Koiso, Saitoh, Takayuki, Murayama, Kayoko, Matsumoto, Morio, Sawamura, Morio, Murakami, Hirokazu, Hirato, Junko, Kojima, Masaru, Nojima, Yoshihisa, Handa, Hiroshi, Tsukamoto, Norifumi

“…Recent studies have revealed the clinical and biological features of stage I follicular lymphoma (FL), but information about patients with stage I FL who…”
Get full text

Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients by Yamasaki, Satoshi, Kada, Akiko, Choi, Ilseung, Iida, Hiroatsu, Sekiguchi, Naohiro, Harada, Naoko, Sawamura, Morio, Shimomura, Takeshi, Komeno, Takuya, Yano, Takahiro, Yoshida, Isao, Yoshida, Shinichiro, Sunami, Kazutaka, Hishita, Terutoshi, Takatsuki, Hiroshi, Ohshima, Koichi, Takeshita, Morishige, Saito, Akiko M., Iwasaki, Hiromi, Nagai, Hirokazu

“…High‐dose chemotherapy and autologous stem cell transplantation (ASCT) are too toxic for elderly patients with relapsed or refractory diffuse large B‐cell…”
Get full text

Reduced risk of bacterial infection in multiple myeloma patients with VAD regimen without intermittent high-dose dexamethasone by Isoda, Atsushi, Matsumoto, Morio, Nakahashi, Hirotaka, Mawatari, Momoko, Manaka, Akihiro, Sawamura, Morio

“…Vincristine-adriamycin-dexamethasone (VAD) regimen with intermittent high-dose dexamethasone (HD) has been used as primary chemotherapy for multiple myeloma…”
Get full text